Peptide Tech

Latest sync: Sep 8, 2026, 8:55 AM. Source coverage currently reflects PB Evidence data.

Peptide Tech ended its public peptide storefront on August 26, 2026. Retained prices and certificates are historical, not current retail offers.

Curated
Independent evidence reviewRead the independent Peptide Tech evidence review
Transparency type
Third-party-linked reports
Access pattern
Publicly inspectable
Best for

Readers who want the retained batch archive and dated price observations from the former public storefront, not a current Peptide Tech vial checkout.

Watch-out

The public storefront is closed. Retained prices are not live offers, and the remaining public site is not a Peptide Tech retail catalog. White-label fulfillment is a separate program and is not modeled as Peptide Tech vial pricing. Peptide Tech said it referred existing customers to another brand; this profile does not identify that brand from the announcement.

Peptide Tech ended its public peptide storefront on August 26, 2026. PeptideBenchmark retains the last public catalog prices and the previously reviewed certificate library as dated historical evidence, not current retail offers.

On August 26, 2026, Peptide Tech announced it was ending its peptide storefront and shifting to lyophilization, filling, and later API synthesis, with a remaining white-label fulfillment program. PeptideBenchmark keeps the last public prices observed August 25 and the previously reviewed public COA library. Those prices are excluded from current Pricing and Stack Builder. The former shopper referral path no longer reaches a Peptide Tech retail checkout.

Testing transparency
Vendor-hosted public documents
Public Verification
Publicly inspectable
Retained public multi-lab COA library with report-level provider verification

The last public COA library contained 162 distinct lot documents from Freedom Diagnostics, Vanguard Laboratory, Janoshik Analytical, Chromate, and SafeCert. PB validates the document bytes and exact product relationship for every retained record. In the July 27 review, 104 distinct Freedom and six Chromate reports resolved at the issuing laboratory; the eight older Janoshik documents no longer resolved at Janoshik’s current verifier and remain named-lab evidence without a provider badge. That library is no longer on the live site; the archive is retained as historical evidence.

Products reviewed
89
Products with certificates
60
Coverage ratio
67%
Avg certs / covered product
2.417

This vendor is one of 113 names currently included in our manual curated research-vendor layer.

View curated vendor pageView transparency viewView compare page

This is the strongest public transparency pattern on the site. The key signal is that readers can leave the vendor domain and inspect reports or verification pages on an outside provider domain without needing to log in.

  • Treat the outside provider route as the strongest part of the evidence, not the vendor marketing copy around it.
  • Look for repeated product-level behavior across the catalog, not just one showcase example.
  • Do not overread it as proof that every current lot is covered or current unless the linked report trail itself supports that.
Read transparency methodologyBrowse similar transparency patterns

This vendor makes the most sense when you compare it to other vendors using a similar transparency model, rather than to every vendor on the board at once.

Open vendor compareOpen vendor/provider bridge

PB Curated Assessment is a PeptideBenchmark-authored rubric built from the trust and transparency review layer. It is separate from the source-derived benchmark score.

Strong curated case

Peptide Tech is currently one of the strongest curated cases on the site because readers can inspect a repeatable public evidence trail without logging in.

Evidence access
Open public verification
Verification structure
Provider-linked
Evidence depth
Broad
Lab context
Multi-lab or multi-category
Evidence access
Open public verification

Readers can leave the vendor marketing layer and inspect verification publicly.

Verification structure
Provider-linked

This is the strongest public pattern because the verification step routes into an outside provider layer.

Evidence depth
Broad

Current review touched 89 products and 162 document/link destinations.

Lab context
Multi-lab or multi-category

5 named lab signal(s) and 1 certification category signal(s) are currently visible in the reviewed evidence.

How to read this benchmark

This profile summarizes public benchmark data synced from Finnrick and, when available, Peptide Critic. Finnrick contributes a 10-point average from its vendor table, while Peptide Critic contributes a 5-star rating that we normalize to a 10-point scale before ranking consensus entries.

A high score can be directionally useful, but it is not a substitute for current COAs, identity testing, chain-of-custody details, or your own due diligence. We are intentionally separating source aggregation from first-party editorial claims.

Scores combine PB trust evidence with external signals from Finnrick, Peptide Critic, Trustpilot, and Pep Review Pro when available.